Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide injection vs curettage for chalazion
IRCT201606156033N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of triamcinolone acetonide in chalazion (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jul 2013; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
chalazion
Beyond the preview
Go deeper on IRCT201606156033N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201606156033N5.